Actor modelling and its contribution to the development of integrative strategies for management of pharmaceuticals in drinking water

Social Science and Medicine

Volumn 68, Issue 4, 2009, Pages 672-681

  Titz, Alexandra ^a   Döll, Petra ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Actor modelling; DANA (Dynamic Actor Network Analysis); Drinking water; Germany; Pharmaceuticals; Risk management strategy

Indexed keywords

DRINKING WATER; DRUG; MODELING; PERCEPTION; RISK ASSESSMENT; SOFTWARE; STRATEGIC APPROACH; WASTE DISPOSAL; WATER RESOURCE; WATER TREATMENT;

COMPUTER SIMULATION; GERMANY; HUMANS; PHARMACEUTICAL PREPARATIONS; POLICY MAKING; PUBLIC POLICY; RISK MANAGEMENT; WATER POLLUTION, CHEMICAL; WATER SUPPLY;

CENTRAL EUROPE; EURASIA; EUROPE; GERMANY;

EID: 59649119204     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.11.031     Document Type: Article

References (40)

1. Assmuth T., Lyytimäki J., Hildén M., Lindholm M., and Münier B. What do experts and stakeholders think about chemical risks and uncertainties? An Internet survey. The Finnish environment Vol. 22 (2007), The Finnish Environment Institute, Helsinki
2. Barceló D., and Petrović M. Pharmaceuticals and personal care products (PPCPs) in the environment. Analytical and Bioanalytical Chemistry 387 4 (2007) 1141-1142
3. Beck A. Environmental assessment of pharmaceuticals in Canada: a regulatory perspective. Drug Information Journal 41 (2007) 159-162
4. BLAC (Bund/Länderausschuss für Chemikaliensicherheit). Arzneimittel in der Umwelt - Auswertung der Untersuchungsergebnisse. Bericht an die 61. Umweltministerkonferenz (UMK) am 19./20. Hamburg (November 2003)
5. Bots P.W.G. Analysis of multi-actor policy contexts using perception graphs. In: Lin T.Y. (Ed). IEEE/WIC/ACM international conference on intelligent agent technology (IAT'07) (2007), IEEE Press, Los Alamos 160-167
6. Bots P.W.G., Van Twist M.J.W., and Van Duin J.H.R. Designing a power tool for policy analysts: dynamic actor network analysis. In: Sprague R.H., and Nunamaker J.F. (Eds). Proceedings of the 32nd annual Hawaii international conference on system sciences Vol. 6 (1999), IEEE Press, Los Alamos 10
7. Bots P.W.G., Van Twist M.J.W., and Van Duin J.H.R. Automatic pattern detection in stakeholder networks. In: Nunamaker J.F., and Sprague R.H. (Eds). Proceedings of the 33rd annual Hawaii international conference on system sciences Vol. 2 (2000), IEEE Press, Los Alamos 10
8. Checkland P.B. Systems thinking, systems practice (1993), John Wiley & Sons Ltd., Chichester
9. Collier A.C. Pharmaceutical contaminants in potable water: potential concerns for pregnant women and children. EcoHealth 4 (2007) 164-171
10. Daughton C.G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environmental Health Perspectives 11 5 (2003) 757-774
11. Daughton C.G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environmental Health Perspectives 11 5 (2003) 775-785
12. Daughton C.G. "Emerging" chemicals as pollutants in the environment: a 21st century perspective. Renewable Resources Journal 23 4 (2005) 6-23
13. Daughton C.G. Pharmaceuticals in the environment: sources and their mitigation. In: Petrović M., and Barceló D. (Eds). Analysis, fate and removal of pharmaceuticals in the water cycle. In: Barceló D. (Ed). Wilson & Wilson's comprehensive analytical chemistry series Vol. 50 (2007), Elsevier, Amsterdam, Oxford 1-58
14. Daughton C.G., and Ternes T. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environmental Health Perspectives 107 6 (1999) 907-938
15. Doerr-MacEwen N.A., and Haight M.E. Expert stakeholders' views and the management of human pharmaceuticals in the environment. Environmental Management 38 (2006) 853-866
16. Döll C., and Döll P. Modellierung der Problemwahrnehmungen und Handlungen von Akteuren im Problemfeld "Mobile organische Fremdstoffe in Gewässern". In: Kohl A., and Mandel B. (Eds). Modellierung und Simulation komplexer geographischer Systeme (2008) 59-75 Salzburg: Salzburger Geographische Arbeiten 43
17. Drewes J.E. Removal of pharmaceutical residues during wastewater treatment. In: Petrović M., and Barceló D. (Eds). Analysis, fate and removal of pharmaceuticals in the water cycle. In: Barceló D. (Ed). Wilson & Wilson's comprehensive analytical chemistry series Vol. 50 (2007), Elsevier, Amsterdam, Oxford 427-450
18. Drewes J.E., Heberer T., and Reddersen K. Fate of pharmaceuticals during indirect potable use. Water Science and Technology 46 2 (2002) 73-80
19. EMEA, Committee for Medicinal Products for Human Use. Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00 (2006), EMEA, London
20. Enick O.V., and Moore M.M. Assessing the assessments: pharmaceuticals in the environment. Environmental Impact Assessment Review 27 (2007) 707-729
21. EPA. Literature citations relevant to pharmaceuticals and personal care products (PPCPs) (2008), U.S. Environmental Protection Agency/Office of Research and Development/National Exposure Research Laboratory. http://www.epa.gov/ppcp/lit.html Accessed 01.07.08
22. FDA. Guidance for industry. Environmental assessment of human drugs and biologics applications (1998), U.S. Department of Health and Human Services/Food and Drug Administration/Center for Drug Evaluation and Research (CDER)/Center for Biologics Evaluation and Research (CBER), Rockville
23. Götz K., and Keil F. Medikamentenentsorgung in privaten Haushalten: Ein Faktor bei der Gewässerbelastung mit Arzneimittelwirkstoffen?. USWF - Z Umweltchemie und Ökotoxikologie 19 3 (2007) 180-188
24. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letter 131 1-2 (2002) 5-17
25. Heberer T. Removal of pharmaceuticals during drinking water production. In: Petrović M., and Barceló D. (Eds). Analysis, fate and removal of pharmaceuticals in the water cycle. In: Barceló D. (Ed). Wilson & Wilson's comprehensive analytical chemistry series Vol. 50 (2007), Elsevier, Amsterdam, Oxford 475-514
26. Khetan S.K., and Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chemical Review 107 (2007) 2319-2364
27. Kümmerer K. Pharmaceuticals in the environment: sources, fate, effects and risks. 2nd ed. (2007), Springer, Berlin
28. Kümmerer K. Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry. Green Chemistry 9 (2007) 899-907
29. Nikolaou A., Meric S., and Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Analytical and Bioanalytical Chemistry 387 4 (2007) 1225-1234
30. Pahl-Wostl C. Participative and stakeholder-based policy design, evaluation and modeling processes. Integrated Assessment 3 1 (2002) 3-14
31. Petrović M., Gonzales S., and Barceló D. Analysis and removal of emerging contaminants in wastewater and drinking water. Trends in Analytical Chemistry 22 10 (2003) 685-696
32. Robinson I., Junqua G., Van Coillie R., and Thomas O. Trends in the detection of pharmaceutical products, and their impact and mitigation in water and wastewater in North America. Analytical and Bioanalytical Chemistry 387 4 (2007) 1143-1151
33. Ruhoy I.S., and Daughton C.G. Types and quantities of leftover drugs entering the environment via disposal to sewage - revealed by coroner records. Science of the Total Environment 388 1-3 (2007) 137-148
34. Stockholm läns landsting (Stockholm City Council). Environmentally classified pharmaceuticals (2008), Stockholm City Council, Stockholm. http://www.janusinfo.se/imcms/servlet/GetDoc?meta_id=10205 Accessed 01.07.08
35. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Research 32 (1998) 3245-3260
36. Ternes T. Abbau und Verhalten von Pharmaka in aquatischen Systemen. Schriftenreihe Wasserforschung 6 (2000) 23-33
37. UBA (Federal Environmental Agency). F&E-Vorhaben 'Mengenermittlung und Systematisierung von Arzneimittelwirkstoffen im Rahmen der Umweltprüfung von Human- und Tierarzneimitteln gemäß §28 AMG' (FKZ 20067401) (2005), UBA, Berlin
38. Vennix J.A.M. Group model building. Facilitating team learning using system dynamics (1996), John Wiley & Sons Ltd, Chichester
39. Von Schomberg R. The precautionary principle and its normative challenges. In: Fisher E., Jones J., and Von Schomberg R. (Eds). Implementing the precautionary principle: Perspectives and prospects (2006), Edward Elgar Publishing, Cheltenham, UK/Northampton, MA, USA 19-42
40. Wennmalm A., and Gunnarsson B. Public health care management of water pollution with pharmaceuticals: environmental classification and analysis of pharmaceutical residues in sewage water. Drug Information Journal 39 3 (2005) 291-297